Verition Fund Management
DAWN

Verition Fund Management’s Day One Biopharmaceuticals DAWN Stock Holding History

Verition Fund Management’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-26,480
Closed -$172K – 3802
2025
Q2 		$172K Sell
26,480
-1,066
-4% -$7.33K ﹤0.01% 3399
2025
Q1 		$218K Sell
27,546
-6,600
-19% -$71.1K ﹤0.01% 3019
2024
Q4 		$433K Buy
34,146
+3,071
+10% +$42.7K ﹤0.01% 2563
2024
Q3 		$433K Buy
31,075
+7,422
+31% +$106K ﹤0.01% 2408
2024
Q2 		$326K Buy
+23,653
New +$346K ﹤0.01% 2294
2023
Q4 		– Sell
-548,757
Closed -$6.73M – 2403
2023
Q3 		$6.73M Buy
548,757
+37,491
+7% +$489K 0.08% 334
2023
Q2 		$6.1M Buy
511,266
+481,935
+1,643% +$6.29M 0.08% 317
2023
Q1 		$392K Buy
+29,331
New +$573K 0.01% 1378

Other funds holding DAWN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Verition Fund Management's DAWN Position: Q3 2025 in Review

Verition Fund Management sold out of Day One Biopharmaceuticals (DAWN) in Q3 2025, closing a stake of 26,480 shares — an estimated $172K sold.

Verition Fund Management first reported a position in DAWN in Q1 2023 and held it in 8 quarters. The position peaked at $6.73M in Q3 2023. 172 funds tracked by Wall St. Rank hold DAWN as of Q3 2025.

  • Verition Fund Management reported no remaining Day One Biopharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Verition Fund Management sold 26,480 Day One Biopharmaceuticals shares in Q3 2025, an estimated $172K.
  • Verition Fund Management first reported a position in Day One Biopharmaceuticals in Q1 2023 and held it in 8 quarters.
  • Verition Fund Management's Day One Biopharmaceuticals position peaked at $6.73M in Q3 2023.
  • 172 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q3 2025.

Based on Verition Fund Management's 13F filing for Q3 2025, filed 14 Nov 2025.